Fig. 1From: Highlights in soft tissue sarcomas and gastrointestinal stromal tumours (GIST) trials reported at ASCO 2017 Annual MeetingOncoKb Level of Evidence system [22] (adapted version). Each mutational event is assigned with a level of clinical actionability (ranging from standard-of-care to investigational or hypothetical treatments)Back to article page